Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P822: Genome-wide association study (GWAS) of a Maltese inflammatory bowel disease cohort

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Schembri*1, N. Pace2, S. Vella1, N. Piscopo1, F. Degenhardt3, A. Franke3, P. Ellul1

1Mater Dei Hospital, Gastroenterology, Msida, Malta, 2University of Malta, Department of Biochemistry, Msida, Malta, 3Christian-Albrechts-University of Kiel, Institute of Clinical Molecular Biology, Kiel, Germany

P823: Study launch: Investigating genetic and environmental factors in the faroese IBD cohort—the INCEPTION study

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Vang*1, K. R. Nielsen2, J. Midjord2, M. á. F. Berbisa1, Ó. Mortensen3, G. Andorsdóttir3,4, N. O. Gregersen3, J. Burisch2

1University of the Faroe Islands, Department of Health and Nursing Sciences, Tórshavn, Faroe Islands, 2National Hospital of the Faroe Islands, Department of Medicine, Tórshavn, Faroe Islands, 3Genetic Biobank of the Faroe Islands, FarGen, Tórshavn, Faroe Islands, 4Genetic Biobank of the Faroe Islands, Tórshavn, Faroe Islands

P824: Phenotypic and genetic markers of disease severity in a Maltese IBD cohort

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Schembri*1, N. Pace2, N. Piscopo1, F. Degenhardt3, A. Franke3, P. Ellul1

1Mater Dei Hospital, Gastroenterology, Msida, Malta, 2University of Malta, Department of Biochemistry, Msida, Malta, 3Christian-Albrechts-University of Kiel, Institute of Clinical Molecular Biology, Kiel, Germany

P825: Low-prevalence of NOD2 polymorphisms in a Maltese IBD cohort

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Schembri*1, N. Pace2, F. Degenhardt3, A. Franke3, P. Ellul1

1Mater Dei Hospital, Gastroenterology, Msida, Malta, 2University of Malta, Department of Biochemistry, Msida, Malta, 3Christian-Albrechts-University Kiel, Institute of Clinical Molecular Biology, Kiel, Germany

P826: Unexplained higher frequency of mutant thiopurine S-methyltransferase genotypes in inflammatory bowel disease patients of Latvia population

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Zalizko*1,2, J. Stefanovics2, R. Erts2, V. Rovite3, J. Klovins3, A. Pukitis1,2

1Pauls Stradins Clinical University Hospital, Gastroenterology, hepatology and nutrition center, Riga, Latvia, 2University of Latvia, Riga, Latvia, 3Latvian Biomedical Research and Study centre, Riga, Latvia

P827: Up-regulation of IL17-related pathways in affected colon from ulcerative colitis compared with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Verstockt*1, F. Ver Donck1, B. Verstockt2,3, E. Glorieus4, M. De Decker5, V. Ballet3, G. Van Assche2,3, D. Laukens4, M. Ferrante2,3, F. Mana5, M. De Vos4, S. Vermeire2,3, I. Cleynen1

1KU Leuven, Department of Human Genetics, Leuven, Belgium, 2KU Leuven, Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), Leuven, Belgium, 3University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 4University Hospital of Ghent, Department of Gastroenterology, Ghent, Belgium, 5University Hospitals Brussels, Department of Gastroenterology, Brussels, Belgium

P828: Network analysis of GWAS reveals differential top-ranked risk loci and proteins associated with the inflammatory bowel disease phenotypes

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Gazouli*1, N. Dovrolis2, A. Franke3, G. Spyrou4, G. Kolios2

1Medical School, National and Kapodistrian University of Athens, Biology, Athens, Greece, 2Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece, 3Institute of Clinical Molecular Biology, Christian-Albrechts-Universität zu Kiel, Kiel, Kiel, Germany, 4Bioinformatics ERA Chair, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus

P829: Mucosal 5-ASA concentration is associated with changes in mucosal bacterial microbiome diversity and composition in patients with quiescent ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Olaisen*1,2,3, O. Spigset1,4, W. R. Brede4, A. Flatberg1, A. v1, B. Granlund1,2,5, E. S. Røyset1,6, A. K. Sandvik1,2,3,5, T. C. Martinsen1,3, R. Fossmark1,2,3

1Norwegian University of Science and Technology (NTNU), Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Trondheim, Norway, 2Liaison Committee between the Central Norway Regional Health Authority (RHA) and NTNU, Trondheim, Norway, 3St. Olav’s Hospital, Trondheim University Hospital, Department of Gastroenterology and Hepatology, Trondheim, Norway, 4St. Olav’s Hospital, Trondheim University Hospital, Department of Clinical Pharmacology, Trondheim, Norway, 5Norwegian University of Science and Technology (NTNU), Centre of Molecular Inflammation Research, Trondheim, Norway, 6St. Olav’s Hospital, Trondheim University Hospital, Department of Pathology, Trondheim, Norway

P830: Adherent-invasive Escherichia coli in inflammatory bowel disease impacts faecal microbiota transplantation efficacy by hindering engraftment of beneficial bacteria

ECCO '19 Copenhagen

Year: 2019
Authors:

Z. Xu*1, K. Yang1, J. Zhang1, T. Zuo1, C. Chevarin2, S. H. Wong1, F. K. Chan1,3, J. J. Sung1, J. Yu1, N. Barnich2, S. C. Ng1,3

1The Chinese University of Hong Kong, Medicine and Therapeutics, Hong Kong, Hong Kong, 2Université Clermont Auvergne, Inserm U1071, Clermont Ferrand, France, 3The Chinese University of Honk Kong, Center for Gut Microbiota Research, Hong Kong, Hong Kong

P831: Gut mucosal virome alterations and loss of viral-bacterial interactions in ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Zuo*1, X. Lu2, C. P. Cheung1, S. Lam1, F. Zhang1, W. Tang1, J. Ching1, R. Zhao1, P. Chan1, J. J. Sung1, J. Yu1, F. K. Chan1, J. Sheng2, S. Ng1

1The Chinese University of Hong Kong, Hong Kong, Hong Kong, 2The General Hospital of the People's Liberation Army, Beijing, China

P832: EEN and CDED produce broadly similar taxonomic changes during the induction of remission, but many taxa rebound upon the transition from EEN back to free diet

ECCO '19 Copenhagen

Year: 2019
Authors:

K. A. Dunn1, J. P. Bielawski1,2, R. Sigall-Boneh3, R. Shamir4, E. Wine5, J. Van Limbergen*6, A. Levine3

1Dalhousie University, Department of Biology, Halifax, Canada, 2Dalhousie University, Department of Mathematics & Statistics, Halifax, Canada, 3PIBD Research Center Paediatric gastroenterology and Nutrition Unit, Wolfson Medical Center, Holon, Israel, 4Institute for Gastroenterology, Nutrition and Liver Diseases, Schneider Children’s Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Tel Aviv, Israel, 5Division of Pediatric Gastroenterology and nutrition, Department of Pediatrics, University of Alberta, Canada, Edmonton, Canada, 6IWK Health Centre / Dalhousie University, Pediatric Gastroenterology, Halifax, Canada

P833: Efficacy of vaccination against hepatitis A in inflammatory bowel disease patients: a single-centre cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Dimas1, E. Voudoukis1, G. Paspatis1, K. Karmiris*1

1Venizeleio General Hospital, Gastroenterology, Heraklion, Greece

P834: Proteus is a key candidate in the pathogenesis of Crohn’s disease: mucosa, stool genomics and functional analysis: the ENIGMA study

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Zhang*1,2, E. Berendsen3, E. Hoedt3, Q. Liu1,2, F. Zhang1,2, Z. Xu1,2, A. Hamilton4,5, A. W. O’ Brien4,5, J. Ching1, J. J. Sung1, M. A. Kamm4,5, M. Morrison3, J. Yu1,2, S. C. Ng1

1The Chinese University of Hong Kong, Medicine & Therapeutics, Hong Kong, Hong Kong, 2The Chinese University of Hong Kong, Institute of Digestive Disease, Hong Kong, Hong Kong, 3The University of Queensland Diamantina Institute, Faculty of Medicine, Brisbane, Australia, 4St Vincent's Hospital, Department of Gastroenterology, Melbourne, Australia, 5The University of Melbourne, Department of Medicine, Melbourne, Australia

P835: Characterisation of fungal microbiota in a Norwegian IBD cohort

ECCO '19 Copenhagen

Year: 2019
Authors:

A. van Beelen Granlund*1,2, S. Thorsvik1,3, I. Catalán-Serra1,4, V. Beisvag2, D. Underhill1,5,6, A. K. Sandvik1,3

1Norwegian University of Science and Technology, Centre for Molecular Inflammation Research, Trondheim, Norway, 2Norwegian University of Science and Technology, Department of Clinical and Molecular Medicine, Trondheim, Norway, 3St Olav’s Hospital, Department of Gastroenterology, Trondheim, Norway, 4Levanger Hospital, Department of Medicine [Gastroenterology], Levanger, Norway, 5Cedars-Sinai Medical Center, Research Division of Immunology, Los Angeles, CA, USA, 6Cedars-Sinai Medical Center, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Los Angeles, CA, USA

P836: The predictive role of gut microbiota in treatment response to vedolizumab and ustekinumab in inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Caenepeel*1, S. Vieira-Silva2, B. Verstockt1,3, M. Ferrante1,3, J. Raes2, S. Vermeire1,3

1KU Leuven, TARGID, Leuven, Belgium, 2Rega Institute for Medical Research, Microbiology and Immunology, Leuven, Belgium, 3University hospitals Leuven, Gastroenterology and Hepatology, Leuven, Belgium

P837: The common food additives sodium sulfite and polysorbate 80 have a profound inhibitory effect on the commensal, anti-inflammatory bacterium Faecalibacterium prausnitzii: the ENIGMA study

ECCO '19 Copenhagen

Year: 2019
Authors:

J. J. Jimenez Loayza1,2, E. M. Berendsen*1,2, J-J. Teh1,2, E. C. Hoedt1,2,3, J. Zhang4,5, Q. Liu4,5, A. L. Hamilton6, A. Wilson-O'Brien6, G. L. Trakman6, W. Lin4,5, W. Tang4,5, J. Ching4,5, L. M. H. Or4,5, J. J. Sung4,5, J. Yu4,5, S. C. Ng4,5,7, M. A. Kamm6, M. Morrison1,2

1The University of Queensland Diamantina Institute, Faculty of Medicine, Brisbane, Australia, 2Translational Research Institute, Brisbane, Australia, 3University College Cork, APC Microbiome Ireland, Cork, Ireland, 4The Chinese University of Hong Kong, Department of Medicine and Therapeutics, Hong Kong, Hong Kong, 5The Chinese University of Hong Kong, LKS Institute of Health Sciences, Institute of Digestive Disease and State Key Laboratory of Digestive Diseases, Hong Kong, Hong Kong, 6The University of Melbourne and St Vincent's Hospital, Melbourne, Department of Medicine and Department of Gastroenterology, Melbourne, Australia, 7The Chinese University of Hong Kong, Centre for Gut Microbiota Research, Hong Kong, Hong Kong

P838: Effects of microbial metabolites on human intestinal epithelium

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Mayorgas*1, E. Ferrer-Picón1, I. Dotti1, A. Corraliza1, N. Planell2, M. Esteller1,2, A. Carrasco2,3, M. C. Masamunt1, M. Esteve2,3, J. Panés1, A. Salas1

1IDIBAPS, Barcelona, Spain, 2CIBERehd, Madrid, Spain, 3Hospital Universitari Mutua de Terrassa, Terrassa, Spain

P840: Dietary interventions rapidly alter metabolomics profile of patients with inflammatory bowel disease after pouch surgery

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Godny*1,2, L. Reshef3, T. Pfeffer-Gik1,2, K. Rabinowitz1,2, I. Goren1,2, K. Yadgar1, K. Zonensain1, R. Barkan1, H. Yanai1,2, U. Gophna3, H. Tulchinsky4, I. Dotan1,2

1Rabin Medical Center, Division of Gastroenterology, Petah-Tikva, Israel, 2Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel, 3Tel Aviv University, Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv, Israel, 4Tel Aviv Sourasky Medical Center, Proctology Unit, Department of Surgery, Tel Aviv, Israel

P841: Small intestinal bacterial overgrowth in patients with Crohn’s disease is not only associated with a more severe disease, but is also marked by dramatic changes in the gut microbiome

ECCO '19 Copenhagen

Year: 2019
Authors:

Y. Kulygina1, M. Osipenko1, M. Skalinskaya2, T. Alikina3, M. Kabilov3, V. Lukinov4, S. Sitkin*2,5

1Novosibirsk State Medical University, Department of Internal Diseases, Novosibirsk, Russian Federation, 2North-Western State Medical University named after I.I. Mechnikov, Department of Internal Diseases, Gastroenterology and Dietetics named after S.M. Ryss, St. Petersburg, Russian Federation, 3Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russian Federation, 4Institute of Computational Mathematics and Mathematical Geophysics SB RAS, Novosibirsk, Russian Federation, 5State Research Institute of Highly Pure Biopreparations of FMBA, Department of Microbiology, St. Petersburg, Russian Federation

P842: Multi-omics analysis suggests an active role of fungi in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Frau*1, U. Z. Ijaz2, R. Hough1, B. J. Campbell1, J. G. Kenny3, N. Hall4, J. Anson5, A. C. Darby3, C. S. J. Probert1

1University of Liverpool, Cellular and Molecular Physiology, Liverpool, UK, 2University of Glasgow, School of Engineering, Glasgow, UK, 3University of Liverpool, Centre for Genomic Research (CGR), Liverpool, UK, 4Earlham Institute, Norwich, UK, 5Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK